Results 31 to 40 of about 1,131,815 (258)

Nomograms predicting Overall Survival and Cancer-specific Survival for Synchronous Colorectal Liver-limited Metastasis [PDF]

Journal of Cancer, 2020
Background: Colorectal cancer (CRC) ranks as the third most frequent cancer type and the second leading cause of cancer-related death worldwide. The liver is the most common metastatic site of CRC with 20%-34% of patients suffering synchronous liver metastasis.
Li, Yuqiang, Liu, Wenxue, Zhao, Lilan, Güngör, Cenap, Xu, Yang, Song, Xiangping, Wang, Dan, Zhou, Zhongyi, Zhou, Yuan, Li, Chenglong, Pei, Qian, Tan, Fengbo, Pei, Haiping   +12 more
openaire   +2 more sources

Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database

BMC Cancer, 2021
Background Hepatocellular carcinoma (HCC) incidences have been increasing in the United States. This study aimed to examine temporal trend of HCC survival and determine prognostic factors influencing HCC survival within the U.S. population.
Jingli Ding, Zhili Wen
doaj   +1 more source

INFLUENCE OF RISK FACTORS FOR DISEASE PROGRESSION ON TREATMENT RESULTS IN PATIENTS WITH PROSTATE CANCER

Сибирский онкологический журнал, 2021
The purpose of the study was to optimize treatment of patients with prostate cancer at high risk of disease progression using a quantitative assessment of risk factors and the treatment method.Material and methods. Immediate outcomes were analyzed in 107
R. M. Isargapov, M. O. Vozdvizhensky, A. L. Gorbachev   +2 more
doaj   +1 more source

Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma [PDF]

Frontiers in Endocrinology, 2021
BackgroundMalignant pheochromocytoma and paraganglioma (PPGL) are rare tumors with few prognostic tools. This study aimed to construct nomograms for predicting 3- and 5-year survival for patients with malignant PPGL.MethodsThe patient data was retrieved from the Surveillance, Epidemiology, and End Results (SEER) database.
Lei Zheng, Yalong Gu, Jiangcun Silang, Jinlong Wang, Feng Luo, Baopeng Zhang, Chuanhong Li, Feng Wang   +7 more
openaire   +3 more sources

Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis

Frontiers in Oncology, 2022
ObjectiveThe objective of this study was to establish and validate novel individualized nomograms for predicting the overall survival (OS) and cancer-specific survival (CSS) in cervical cancer patients with lymph node metastasis.MethodsA total of 2,956 ...
Jianying Yi, Zhili Liu, Zhili Liu, Zhili Liu, Zhili Liu, Lu Wang, Xingxin Zhang, Lili Pi, Chunlei Zhou, Hong Mu   +9 more
doaj   +1 more source

Nomograms predicting overall survival and cancer-specific survival in osteosarcoma patients (STROBE)

Medicine, 2019
Abstract The aim of this study was to develop nomograms to predict long-term overall survival and cancer-specific survival of patients with osteosarcoma. We carried out univariate and multivariate analyses and set up nomograms predicting survival outcome using osteosarcoma patient data collected from the ...
Chen, Wenhao, Lin, Yuxiang
openaire   +2 more sources

Nomogram prediction for the overall survival and cancer-specific survival of patients diagnosed with Merkel cell carcinoma [PDF]

Annals of Translational Medicine, 2021
Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine carcinoma of the skin, with a high recurrence rate and a high mortality rate worldwide. The purpose of this article is to construct a nomogram that incorporates significant clinical parameters and predicts the survival of individuals with MCC.The Surveillance, Epidemiology, and End ...
Yin, Xufeng, She, Huihui, Martin Kasyanju Carrero, Lorna, Ma, Weiwei, Zhou, Bingrong   +4 more
openaire   +2 more sources

Nomogram for predicting the overall survival and cancer-specific survival of patients with extremity liposarcoma: a population-based study

BMC Cancer, 2020
Background Extremity liposarcoma represents 25% of extremity soft tissue sarcoma and has a better prognosis than liposarcoma occurring in other anatomic sites. The purpose of this study was to develop two nomograms for predicting the overall survival (OS)
Lin Ye, Chuan Hu, Cailin Wang, Weiyang Yu, Feijun Liu, Zhenzhong Chen   +5 more
doaj   +1 more source

Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis

BMC Cancer, 2021
Background Previous studies have reported poor survival rates in inflammatory breast cancer (IBC) patients than non-inflammatory local advanced breast cancer (non-IBC) patients.
Dechuang Jiao, Jingyang Zhang, Jiujun Zhu, Xuhui Guo, Yue Yang, Hui Xiao, Zhenzhen Liu   +6 more
doaj   +1 more source

Neighborhood Disadvantage and Breast Cancer-Specific Survival in the US.

JAMA Netw Open
ImportanceDespite improvements in breast cancer screening, treatment, and survival, disparate breast cancer–specific survival outcomes persist, particularly in disadvantaged neighborhoods. Most of these disparities are attributed to disparities in individual, tumor, and treatment characteristics.
Goel N, Hernandez AE, Mazul A.
europepmc   +5 more sources